Abstract

Aim: Transrectal ultrosound-accompanied biopsy is the gold procedure for the histological diagnosis of prostate cancer. In this study, purpose to determine the prevalence of fluoroquinolone resistance Escherichia coli in intestinal flora of patients undergoing prostate biopsies with rectal swab culture. In addition, other antibiotics can be used in prostate biopsy prophylaxis was to determine the susceptibility. Materials Methods: This study involved 56 who were indicated with the prostate biopsy between April 2012 – October 2013 with prostate cancer suspicion were included in the study. The rectal samples culture were obtained from each patient before prostate biopsy. The patients who have a prostate biopsy history and prostate surgical operation history were excluded from the study. The records for the infections of those patients after the operation were kept. Findings: In this study, rectal swab culture were obtained from 56 patients. Rectal swab cultures taken from 56 patients ranged from 50 to 74 years of age was calculated as the average of 61. In 44 of the samples of E. coli produce. The lowest rates of resistance against to amikacin (2.3%) were detected. In 11 cases (25%) was detected in fluoroquinolone-resistant E. coli isolates. Developing a urinary tract infection after the procedure because of cases were hospitalized. The cases of rectal swab and urine in culture, fluoroquinolone-resistant E. coli was detected. The blood cultures were negative. Conclusion: We have found high number of fluoroquinolone resistant E. Coli strains in the rectal swab culture taken before the prostate biopsy. The fluoroquinolone resistance in the standart prophylaxis applications before the prostate biopsy should be kept in mind. Risk patients, rectal swab culture can be used in targeted prophylaxis.